Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,518 JPY | -1.68% | -5.12% | -12.71% |
2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.71% | 240M | |
+29.98% | 682B | |
+32.39% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.50% | 240B | |
+9.56% | 209B | |
-9.04% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- 4554 Stock
- News Fuji Pharma Co., Ltd.
- Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan